In addition, even though we did not detect any differences in the plasma levels of IL-26 between patients with COVID-19 who received corticosteroids (a common treatment for COVID-19 and asthma) and those who did not, we cannot exclude the possibility that other drugs taken during sample collection might have had an impact on the systemic levels of IL-26 in certain patients. Here, IL26 is linked to asthma.